| Net Cash Provided by (Used in) Operating Activities |
$31,157,000 |
USD |
-122% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$122,675,000 |
USD |
-77% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$3,276,000 |
USD |
-1146% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
85,990,320 |
shares |
-8.1% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$157,108,000 |
USD |
-309% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$791,961,000 |
USD |
17% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$3,400,000 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Gross |
$100,339,000 |
USD |
5.6% |
Q4 2024 |
FY 2024 |
| Operating Lease, Liability |
$88,022,000 |
USD |
14% |
Q3 2025 |
Q3 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$8,105,000 |
USD |
26% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$7,387,000 |
USD |
0.82% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$96,981,000 |
USD |
5.8% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
$32,649,000 |
USD |
12% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |